Apollo Hospitals pharmacy demerger.

Apollo Hospitals Enterprise has announced plans to hive off its pharmacy distribution and digital-health business into a new entity called “Apollo Healthtech”, to be listed on the stock exchanges in the next 18–21 months . Existing shareholders of Apollo Hospitals will receive 195.2 new shares in the new company for every 100 Apollo shares held.

Apollo Hospitals will retain a 15% stake in Apollo Healthtech and have representation on its board.

The new entity will consolidate:

  • Keimed, the pharmacy distributor,
  • Apollo 24/7 hub for digital-health services, and
  • Apollo’s omnichannel pharmacy platform currently managed under Apollo HealthCo

Revenue for FY ending March 2027 is projected at ₹250,000 million (~USD 2.9 billion), with an EBITDA margin target of ~7% .At present, Apollo HealthCo’s Q4 FY25 revenue reached ₹90,930 million, marking 16% YoY growth; it operates over 6,600 pharmacies and has a robust digital platform (Apollo 24/7)

sources

Scroll to Top